Your first visit is a comprehensive consultation. We will review your medical history, discuss your goals, and likely perform an initial ultrasound (preferably at the mid cycle). We will also order basal blood tests (Day 1-4) and a semen analysis to begin building your personalized treatment plan.

IUI (Intrauterine Insemination) is a lower-tech procedure where prepared sperm is placed directly into the uterus around the time of ovulation. IVF (In Vitro Fertilization) is more advanced; eggs are surgically retrieved, fertilized with sperm in our lab, and the resulting embryo is then transferred into the uterus.

A standard IVF cycle takes about 4 to 6 weeks. This includes roughly 10–12 days of ovarian stimulation (injections), the egg retrieval procedure, and then either a fresh embryo transfer 2-5 days later or a frozen transfer in a subsequent month.

Most patients describe the process as "uncomfortable" rather than "painful." The daily injections use very small needles (similar to insulin needles). The egg retrieval is performed under light sedation, so you won't feel anything during the procedure, though you may have mild cramping afterward.

Success rates depend heavily on age, BMI and the underlying cause of subfertility. For women under 35, our "live birth per transfer" rate is approximately 45%, which gets lower with older age groups up to 5% in women above 43.

Our goal is a "healthy singleton" (one baby). In IVF, we achieve this by eSET (elective Single Embryo Transfer). While IUI has a slightly higher risk of multiples because we cannot control how many eggs fertilize, we monitor your cycle closely to minimize this risk.

Yes. We recommend all patients take a high-quality prenatal vitamin with at least 400mcg of folic acid. Depending on your labs, we may also suggest Vitamin D, and other supplements.

During the stimulation phase of IVF, we recommend "ovarian rest"—limiting high-impact exercise like running or HIIT to avoid the risk of ovarian torsion (twisting). Walking, light yoga, and swimming are generally encouraged.

Coverage varies wildly by provider and state. Our dedicated Financial Coordinators will perform a "Benefits Verification" for you before you start treatment to help you understand your out-of-pocket costs.

PGT is a screening process performed during IVF to check the genetic or chromosomal makeup of an embryo before it is transferred to the uterus. Its primary goals are to increase the chances of a healthy pregnancy, reduce the risk of miscarriage, and avoid passing on specific genetic conditions.

There are three main types, each serving a different purpose:

• PGT-A (Aneuploidy): Screens for the correct number of chromosomes (46). Most miscarriages are caused by an incorrect number of chromosomes.
• PGT-M (Monogenic): Tests for a specific single-gene disorder (like Cystic Fibrosis or Huntington's Disease) if parents are known carriers.
• PGT-SR (Structural Rearrangements): Used if a parent has a chromosomal translocation or inversion that could lead to an unbalanced embryo.

In experienced hands, the risk is very low (less than 1%). We perform the biopsy at the blastocyst stage (Day 5 or 6), removing a few cells from the trophectoderm (the part that becomes the placenta). The inner cell mass (the part that becomes the baby) is left untouched.

Because PGT analysis takes roughly 7 to 14 days, your embryos will be frozen (cryopreserved) immediately after the biopsy. You will then schedule a Frozen Embryo Transfer (FET) in a subsequent cycle once the results are ready.

PGT is highly accurate, generally ranging from 97% to 99%. However, it is a screening test, not a 100% diagnostic guarantee. We still recommend standard prenatal screenings once you are pregnant to confirm the health of the baby.

A mosaic result means the sample contained a mixture of both normal and abnormal cells. While euploid (normal) embryos are prioritized, many "low-level" mosaic embryos can still result in perfectly healthy births. If you receive a mosaic result, you will meet with our Genetic Counselor to discuss your options.

Since PGT-A looks at all chromosomes, including the sex chromosomes (X and Y), the sex of each embryo is identified. Gender selection will be discussed, and it will be subjected to individual medical and social circumstances and regulations to be approved or not.

While PGT adds an upfront cost (typically $3,000–$6,000 depending on the number of embryos), it can save you money and emotional heartache in the long run by avoiding unsuccessful transfers or miscarriages. It is especially recommended for:

• Women over the age of 35.
• Couples with a history of recurrent pregnancy loss.
• Couples with multiple failed IVF cycles.